Skip to main content

Advertisement

SpringerLink
Log in

Expression of inflammatory secretory phospholipase A2 and cytosolic phospholipase A2 in premalignant and malignant Barrett’s oesophagus

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

Aims

To establish the prevalence of inflammatory secretory phospholipase A2 (sPLA2) and cytoplasmic phospholipase A2 (cPLA2) expression in a surgical series of Barrett’s adenocarcinoma and associated preneoplastic lesions and to correlate this expression with clinicopathological data and prognosis.

Methods

sPLA2 and cPLA2 were analysed by means of immunohistochemistry in surgical specimens of 67 and 73 cases of Barrett’s adenocarcinomas, respectively. Barrett’s mucosa was analysed in 31 cases.

Results

Expression of sPLA2 was detected in 48% of Barrett’s mucosa negative for intraepithelial neoplasia and 63% of Barrett’s adenocarcinoma. Semi-quantitative analysis revealed a significant increase in sPLA2 expression between Barrett’s mucosa negative for intraepithelial neoplasia and adenocarcinoma. cPLA2 expression was detected in 18% of Barrett’s adenocarcinoma. An inverse correlation was found between cPLA2 expression and depth of tumour infiltration, neoplastic vascular invasion and neoplastic perineural invasion. Survival analysis showed no significant prognostic value for sPLA2 and cPLA2.

Conclusion

sPLA2 is frequently expressed in Barrett’s oesophagus. The increasing expression of sPLA2 that we observed from Barrett’s mucosa to adenocarcinoma suggests that sPLA2 could be involved in Barrett’s carcinogenesis. In contrast, cPLA2 expression is less frequently observed in Barrett’s oesophagus and is inversely associated with aggressive pathological features of the tumours.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Balsinde J, Balboa MA, Dennis EA (1998) Functional coupling between secretory phospholipase A2 and cyclooxygenase-2 and its regulation by cytosolic group IV phospholipase A2. Proc Natl Acad Sci USA 95:7951–7956

    Article  CAS  PubMed  Google Scholar 

  2. Balsinde J, Balboa MA, Insel PA, Dennis EA (1999) Regulation and inhibition of phospholipase A2. Annu Rev Pharmacol Toxicol 39:175–189

    Google Scholar 

  3. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr (1991) Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265:1287–1289

    CAS  PubMed  Google Scholar 

  4. Buttar NS, Wang KK, Leontovich O, Westcott JY, Pacifico RJ, Anderson MA, Krishnadath KK, Lutzke LS, Burgart LJ (2002) Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett’s esophagus. Gastroenterology 122:1101–1112

    CAS  PubMed  Google Scholar 

  5. Cameron AJ (2002) Epidemiology of Barrett’s esophagus and adenocarcinoma. Dis Esophagus 15:106–108

    Article  CAS  PubMed  Google Scholar 

  6. Clark JD, Schievella AR, Nalefski EA, Lin LL (1995) Cytosolic phospholipase A2. J Lipid Mediat Cell Signal 12:83–117

    Article  CAS  PubMed  Google Scholar 

  7. Cormier RT, Hong KH, Halberg RB, Hawkins TL, Richardson P, Mulherkar R, Dove WF, Lander ES (1997) Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Nat Genet 17:88–91

    CAS  PubMed  Google Scholar 

  8. Dobbie Z, Muller H, Scott RJ (1996) Secretory phospholipase A2 does not appear to be associated with phenotypic variation in familial adenomatous polyposis. Hum Genet 98:386–390

    Article  CAS  PubMed  Google Scholar 

  9. Dong M, Guda K, Nambiar PR, Rezaie A, Belinsky GS, Lambeau G, Giardina C, Rosenberg DW (2003) Inverse association between phospholipase A2 and COX-2 expression during mouse colon tumorigenesis. Carcinogenesis 24:307–315

    Article  CAS  PubMed  Google Scholar 

  10. Faller G, Borchard F, Ell C, Seitz G, Stolte M, Walch A, Ruschoff J, Working Group for Gastroenterological Pathology of the German Society for Pathology (2003) Histopathological diagnosis of Barrett’s mucosa and associated neoplasias: results of a consensus conference of the Working Group for Gastroenterological Pathology of the German Society for Pathology on 22 September 2001 in Erlangen. Virchows Arch 443:597–601

    Article  CAS  PubMed  Google Scholar 

  11. Graff JR, Konicek BW, Deddens JA, Chedid M, Hurst BM, Colligan B, Neubauer BL, Carter HW, Carter JH (2001) Expression of group IIa secretory phospholipase A2 increases with prostate tumor grade. Clin Cancer Res 7:3857–3861

    CAS  PubMed  Google Scholar 

  12. Haapamaki MM, Gronroos JM, Nurmi H, Alanen K, Kallajoki M, Nevalainen TJ (1997) Gene expression of group II phospholipase A2 in intestine in ulcerative colitis. Gut 40:95–101

    CAS  PubMed  Google Scholar 

  13. Haapamaki MM, Gronroos JM, Nurmi H, Alanen K, Nevalainen TJ (1999) Gene expression of group II phospholipase A2 in intestine in Crohn’s disease. Am J Gastroenterol 94:713–720

    CAS  PubMed  Google Scholar 

  14. Hameeteman W, Tytgat GN, Houthoff HJ, van den Tweel JG (1989) Barrett’s esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 96:1249–1256

    CAS  PubMed  Google Scholar 

  15. Heasley LE, Thaler S, Nicks M, Price B, Skorecki K, Nemenoff RA (1997) Induction of cytosolic phospholipase A2 by oncogenic Ras in human non-small cell lung cancer. J Biol Chem 272:14501–14504

    Article  CAS  PubMed  Google Scholar 

  16. Hong KH, Bonventre JC, O’Leary E, Bonventre JV, Lander ES (2001) Deletion of cytosolic phospholipase A(2) suppresses Apc(Min)-induced tumorigenesis. Proc Natl Acad Sci U S A 98:3935–3939

    Article  CAS  PubMed  Google Scholar 

  17. Jenkins GJ, Doak SH, Parry JM, D’Souza FR, Griffiths AP, Baxter JN (2002) Genetic pathways involved in the progression of Barrett’s metaplasia to adenocarcinoma. Br J Surg 89:824–837

    Article  CAS  PubMed  Google Scholar 

  18. Kashiwagi M, Friess H, Uhl W, Berberat P, Abou-Shady M, Martignoni M, Anghelacopoulos SE, Zimmermann A, Buchler MW (1999) Group II and IV phospholipase A(2) are produced in human pancreatic cancer cells and influence prognosis. Gut 45:605–612

    CAS  PubMed  Google Scholar 

  19. Kaur BS, Khamnehei N, Iravani M, Namburu SS, Lin O, Triadafilopoulos G (2002) Rofecoxib inhibits cyclooxygenase 2 expression and activity and reduces cell proliferation in Barrett’s esophagus. Gastroenterology 123:60–67

    Article  CAS  PubMed  Google Scholar 

  20. Kennedy BP, Soravia C, Moffat J, Xia L, Hiruki T, Collins S, Gallinger S, Bapat B (1998) Overexpression of the nonpancreatic secretory group II PLA2 messenger RNA and protein in colorectal adenomas from familial adenomatous polyposis patients. Cancer Res 58:500–503

    CAS  PubMed  Google Scholar 

  21. Kiyohara H, Egami H, Shibata Y, Murata K, Ohshima S, Ogawa M (1992) Light microscopic immunohistochemical analysis of the distribution of group II phospholipase A2 in human digestive organs. J Histochem Cytochem 40:1659–1664

    CAS  PubMed  Google Scholar 

  22. Lagorce C, Fléjou JF, Muzeau F, Hénin D, Potet F (1995) Absence of c-Ki-ras gene mutation in malignant and premalignant Barrett’s oesophagus. J Clin Pathol 48:M198–M199

    CAS  Google Scholar 

  23. Lagorce C, Paraf F, Vidaud D, Couvelard A, Wendum D, Martin A, Flejou JF (2003) Cyclooxygenase-2 is expressed frequently and early in Barrett’s oesophagus and associated adenocarcinoma. Histopathology 42:457–465

    CAS  PubMed  Google Scholar 

  24. Laurén P (1965) The two histological main types of gastric carcinoma diffuse and so-called intestinal type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31–49

    CAS  Google Scholar 

  25. Leung SY, Chen X, Chu KM, Yuen ST, Mathy J, Ji J, Chan AS, Li R, Law S, Troyanskaya OG, Tu IP, Wong J, So S, Botstein D, Brown PO (2002) Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis. Proc Natl Acad Sci U S A 99:16203–16208

    Article  CAS  PubMed  Google Scholar 

  26. MacPhee M, Chepenik KP, Liddell RA, Nelson KK, Siracusa LD, Buchberg AM (1995) The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia. Cell 81:957–966

    CAS  PubMed  Google Scholar 

  27. Morris CD, Armstrong GR, Bigley G, Green H, Attwood SE (2001) Cyclooxygenase-2 expression in the Barrett’s metaplasia-dysplasia-adenocarcinoma sequence. Am J Gastroenterol 96:990–996

    Article  CAS  PubMed  Google Scholar 

  28. Murakami M, Shimbara S, Kambe T, Kuwata H, Winstead MV, Tischfield JA, Kudo I (1998) The functions of five distinct mammalian phospholipase A2S in regulating arachidonic acid release. Type IIa and type V secretory phospholipase A2S are functionally redundant and act in concert with cytosolic phospholipase A2. J Biol Chem 273:14411–14423

    Article  CAS  PubMed  Google Scholar 

  29. Murata K, Egami H, Kiyohara H, Oshima S, Kurizaki T, Ogawa M (1993) Expression of group-II phospholipase A2 in malignant and non-malignant human gastric mucosa. Br J Cancer 68:103–111

    CAS  PubMed  Google Scholar 

  30. Niessen HW, Krijnen PA, Visser CA, Meijer CJ, Erik Hack C (2002) Type II secretory phospholipase A2 in cardiovascular disease: a mediator in atherosclerosis and ischemic damage to cardiomyocytes? Cardiovasc Res 53:138–146

    Article  PubMed  Google Scholar 

  31. Paraf F, Flejou JF, Pignon JP, Fekete F, Potet F (1995) Surgical pathology of adenocarcinoma arising in Barrett’s esophagus. Analysis of 67 cases. Am J Surg Pathol 19:183–191

    CAS  PubMed  Google Scholar 

  32. Rosenberg JC, Budev H, Edwards RC, Singal S, Steiger Z, Sundareson AS (1985) Analysis of adenocarcinoma in Barrett’s esophagus utilizing a staging system. Cancer 55:1353–1360

    CAS  PubMed  Google Scholar 

  33. Shirvani VN, Ouatu-Lascar R, Kaur BS, Omary MB, Triadafilopoulos G (2000) Cyclooxygenase 2 expression in Barrett’s esophagus and adenocarcinoma: ex vivo induction by bile salts and acid exposure. Gastroenterology 118:487–496

    CAS  PubMed  Google Scholar 

  34. Six DA, Dennis EA (2000) The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochim Biophys Acta 1488:1–19

    CAS  Google Scholar 

  35. Sobin LH, Wittekind Ch (1997) TNM classification of malignant tumors. Wiley-Liss, Inc, New-York

  36. Soydan AS, Gaffen JD, Weech PK, Tremblay NM, Kargman S, O’Neill G, Bennett A, Tavares IA (1997) Cytosolic phospholipase A2, cyclo-oxygenases and arachidonate in human stomach tumours. Eur J Cancer 33:1508–1512

    CAS  PubMed  Google Scholar 

  37. Soydan AS, Tavares IA, Weech PK, Temblay NM, Bennett A (1996) High molecular weight phospholipase A2 and fatty acids in human colon tumours and associated normal tissue. Eur J Cancer 32:1781–1787

    Article  Google Scholar 

  38. Spechler SJ, Goyal RK (1986) Barrett’s esophagus. N Engl J Med 315:362–371

    CAS  PubMed  Google Scholar 

  39. Spirio LN, Kutchera W, Winstead MV, Pearson B, Kaplan C, Robertson M, Lawrence E, Burt RW, Tischfield JA, Leppert MF, Prescott SM, White R (1996) Three secretory phospholipase A(2) genes that map to human chromosome 1P35–36 are not mutated in individuals with attenuated adenomatous polyposis coli. Cancer Res 56:955–958

    CAS  PubMed  Google Scholar 

  40. Takaku K, Sonoshita M, Sasaki N, Uozumi N, Doi Y, Shimizu T, Taketo MM (2000) Suppression of intestinal polyposis in Apc(delta 716) knockout mice by an additional mutation in the cytosolic phospholipase A(2) gene. J Biol Chem 275:34013–34016

    CAS  PubMed  Google Scholar 

  41. Wendum D, Svrcek M, Rigau V, Boelle PY, Sebbagh N, Parc R, Masliah J, Trugnan G, Flejou JF (2003) COX-2, Inflammatory Secreted PLA2, and cytoplasmic PLA2 protein expression in small bowel adenocarcinomas compared with colorectal adenocarcinomas. Mod Pathol 16:130–136

    PubMed  Google Scholar 

  42. World Health Organization Classification of Tumours (2000) Pathology and genetics of tumours of the digestive system. Hamilton SR, Aaltonen LA

  43. Yamashita S, Yamashita J, Ogawa M (1994) Overexpression of group II phospholipase A2 in human breast cancer tissues is closely associated with their malignant potency. Br J Cancer 69:1166–1170

    CAS  PubMed  Google Scholar 

  44. Ying Z, Tojo H, Komatsubara T, Nakagawa M, Inada M, Kawata S, Matsuzawa Y, Okamoto M (1994) Enhanced expression of group II phospholipase A2 in human hepatocellular carcinoma. Biochim Biophys Acta 1226:201–205

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This works was supported in part by grants from Association Charles Debray. We thank K. Aliouat, F. Bouchard, V. Creusot, S. Dufflot, B. Lejeune, M. Pelegrin (Service d’Anatomie Pathologique, Hôpital Avicenne, Bobigny) for their technical assistance.

Author information

Authors and Affiliations

  1. Service d’Anatomie Pathologique, Hôpital Avicenne, AP-HP, Bobigny, France

    Christine Lagorce-Pagès & Antoine Martin

  2. Service d’Anatomie Pathologique, Hôpital Dupuytren, Limoges, France

    François Paraf

  3. Service d’Anatomie Pathologique A, Hôpital Saint Antoine, AP-HP, 184 rue du Faubourg Saint-Antoine, 75541, Paris Cedex 12, France

    Dominique Wendum & Jean-François Fléjou

Authors
  1. Christine Lagorce-Pagès
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. François Paraf
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dominique Wendum
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Antoine Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jean-François Fléjou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jean-François Fléjou.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lagorce-Pagès, C., Paraf, F., Wendum, D. et al. Expression of inflammatory secretory phospholipase A2 and cytosolic phospholipase A2 in premalignant and malignant Barrett’s oesophagus. Virchows Arch 444, 426–435 (2004). https://doi.org/10.1007/s00428-004-1003-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-004-1003-7

Key words

Search

Navigation